NasdaqCM - Nasdaq Real Time Price USD

Aditxt, Inc. (ADTX)

1.4900
-0.0200
(-1.32%)
At close: June 10 at 4:00:00 PM EDT
1.4900
0.00
(0.00%)
After hours: June 10 at 6:28:37 PM EDT

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Amro A. Albanna Co-Founder, Chairman & CEO 500k -- 1970
Dr. Shahrokh Shabahang D.D.S., M.S., Ph.D. Co-Founder, Chief Innovation Officer, Secretary & Director 325k -- 1964
Mr. Thomas J. Farley CPA Chief Financial Officer 464.62k -- 1974
Ms. Corinne D. Pankovcin CPA, M.B.A. Chief Mergers & Acquisitions Officer 385.01k -- 1966
Ms. Rowena Albanna Chief Operating Officer -- -- 1966
Ms. Jennifer Lee Director of Human Resources -- -- --
Dr. Dolly B. Tyan D(ABHI), Ph.D. Senior Vice President of Clinical Development – Transplantation -- -- --
Mr. Ge Chen M.D., M.S. Senior Vice President of Preclinical Research & Discovery -- -- --

Aditxt, Inc.

2569 Wyandotte Street
Suite 101
Mountain View, CA 94043
United States
650 870 1200 https://www.aditxt.com
Sector: 
Healthcare
Industry: 
Biotechnology
Full Time Employees: 
26

Description

Aditxt, Inc., a commercial-stage company, discovers and develops products in the areas of immune health, precision health, population health, women's health, and neurologic health. The company develops AditxtScore that enable individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its tissues. It also develops ADI-100 for skin grafting, psoriasis, type 1 diabetes, and multiple sclerosis. Aditxt, Inc. has a license agreement with Loma Linda University and Leland Stanford Junior University. The company was formerly known as ADiTx Therapeutics, Inc. and changed its name to Aditxt, Inc. in July 2021. Aditxt, Inc. was incorporated in 2017 and is headquartered in Mountain View, California.

Corporate Governance

Aditxt, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

August 18, 2025 at 8:00 PM UTC - August 22, 2025 at 8:00 PM UTC

Aditxt, Inc. Earnings Date

Recent Events

June 9, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

June 2, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

May 27, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

May 19, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

May 15, 2025 at 12:00 AM UTC

10-Q: Periodic Financial Reports

May 5, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

April 25, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

April 22, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

April 17, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

April 15, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

Related Tickers